 | • レポートコード：MRC2103E448 • 出版社/出版日：Mordor Intelligence / 2021年1月 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：バイオ |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料では、世界のバイオアナリシスにおけるラボ自動化市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、提供別（機器、ソフトウェア）分析、分析装置別（生化学分析装置、免疫ベース分析装置、血液分析装置、セルカウンター、凝固計）分析、地域別分析、競争状況、投資分析、市場機会・将来動向などの項目を掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界のバイオアナリシスにおけるラボ自動化市場規模：提供別（機器、ソフトウェア） ・世界のバイオアナリシスにおけるラボ自動化市場規模：分析装置別（生化学分析装置、免疫ベース分析装置、血液分析装置、セルカウンター、凝固計） ・世界のバイオアナリシスにおけるラボ自動化市場規模：地域別 ・競争状況 ・投資分析 ・市場機会・将来動向 |
The lab automation in bioanalysis market was valued at USD 5.06 billion in 2020 and is expected to reach USD 7.10 billion by 2026, at a CAGR of 5.8% over the forecast period (2021 – 2026). Lab automation is required in bioanalysis applications, as manual and traditional handling can result in a corrupted or infected sample. The emergence of automated solutions, such as automated liquid handlers, automated plate handlers, and robotics, has eliminated the need for human intervention in bioanalysis laboratories by increasing accuracy and improving efficiency.
– For clinical trials, it is sometimes imperative to monitor drug levels in subjects in real-time, which enables medical monitors and clinical investigators to adjust the dosing to meet the subject’s needs and study requirements. Thus, clinical trials and diagnostics require bioanalysis technologies. Automated handling makes it easier to obtain error-free results. Owing to the rise in the number of clinical trials and studies and the growth in complexity, lab automation in bioanalysis is projected to experience significant demand.
– Various aspects, such as growing reproducibility and accuracy, miniaturization in the process, progressing drug discovery, clinical diagnostics, and the large gap in workforce demand and supply, have driven the growth of the market across the world. Moreover, factors, such as technological innovations leading to device miniaturization and increased throughput and rising demand for personalized medicines, are significantly driving the market growth.
– However, high capital requirements for setup will be a major hindrance to market growth.
Key Market Trends
Robotic Arms to be the Fastest Growing Equipment Segment
– Robotic arms in lab automation are used for chemical analysis. Pharmaceutical companies are employing robots to move samples around the workspace for diagnosing chemical entities from the existing sample. Robotic arms are used for sample handling, coupled with new technologies, to eliminate errors.
– The pharmaceutical industry has experienced increased use of robotic arms, as the synthesizing of samples with structural analysis can be done automatically. Robotic arms are used in applications, like biological and combinatorial chemistry for sample diagnosis, with automation increasing the market’s standards.
– Further, robotic arms also help in doing the mundane task in the laboratory set up saving time and energy of a human being doing that task. According to IFR, World Robotics 2018, sales of medical robots increased by 73% compared in 2016 to 2,931 units in 2017, accounting for a share of 2.7% of the total unit sales of professional service robots. The major reason identified for an increased sale has been the wide use in robotic surgery and laboratory automation in clinics.
North America to Hold Largest Market Share
– A rise in the number of global clinical and pre-clinical studies has made the need for speedy analysis of samples imperative, making automation one of the key components contributing to the growth of the market.
– Various aspects, such as growing reproducibility and accuracy, miniaturization in the process, progressing drug discovery, clinical diagnostics, and the large gap in workforce demand and supply, have driven the growth of the market across the world. Cost-effectiveness, owing to routine work, professional labor cost, and precise handling, is a variable that impacts the demand for these solutions.
– Strict regulations by the US government and the FDA, the growing demand in the diagnostic market, and the increasing usage of discovery and research labs, owing to the rising presence of various diseases, such as cardiovascular diseases and neurological diseases in the region, have fueled the growth of the market. The US dominates the North American market and is the major revenue contributor in the region.
Competitive Landscape
The lab automation in bioanalysis market is consolidated. Major players have the maximum market share. Also, the players in the lab automation in bioanalysis market are increasingly competing against each other based on factors, such as product innovations and technological advances. Some of the key players include Thermo Fisher Scientific, Beckman Coulter (Danaher Corporation), Hudson Robotics, Becton Dickinson, Synchron Lab Automation, Agilent Technologies, Siemens Healthcare, Tecan Group Ltd, PerkinElmer, Bio-Rad, Roche Holding AG, Eppendorf AG, Shimadzu, and Aurora Biomed, among others.
– May 2019 – Beckman Coulter, announced the latest addition to its automation portfolio. The DxA 5000 total laboratory automation solution has achieved European CE Mark and China Food and Drug Administration approval. In the healthcare environment, laboratories are highly focused on enhancing patient care, by driving faster turnaround time, delivering quality results, and improving laboratory operations. The DxA 5000 helps laboratories meet these challenges through a collection of patented innovations that deliver rapid and consistent turnaround time, provide a new level of comprehensive pre-analytical sample quality detection, and reduce the number of manual processing steps to significantly improve laboratory efficiency.
– September 2018 – Tecan successfully completed the acquisition of NuGEN Technologies.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Demand for Personalized Medicines
4.2.2 Technological Innovations Resulting in Improved Solutions
4.3 Market Restraints
4.3.1 High Capital Requirements for Setup
4.4 Industry Value Chain Analysis
4.5 Industry Attractiveness – Porter’s Five Forces Analysis
4.5.1 Bargaining Power of Suppliers
4.5.2 Bargaining Power of Buyers/Consumers
4.5.3 Threat of New Entrants
4.5.4 Threat of Substitute Products
4.5.5 Intensity of Competitive Rivalry
4.6 Technology Snapshot
5 MARKET SEGMENTATION
5.1 By Offering
5.1.1 Equipment
5.1.1.1 Automated Liquid Handlers
5.1.1.2 Automated Plate Handlers
5.1.1.3 Robotic Arms
5.1.1.4 AS/RS
5.1.1.5 Vision Systems
5.1.2 Software
5.2 By Analyzers
5.2.1 Biochemistry Analyzers
5.2.2 Immuno-Based Analyzers
5.2.3 Hematology Analyzers
5.2.4 Cell Counters
5.2.5 Coagulometers
5.3 Geography
5.3.1 North America
5.3.2 Europe
5.3.3 Asia-Pacific
5.3.4 Latin America
5.3.5 Middle East & Africa
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Thermo Fisher Scientific Inc.
6.1.2 Agilent Technologies
6.1.3 Beckman Coulter Inc. (Danaher Corporation)
6.1.4 Hamilton Company
6.1.5 Hudson Robotics Inc.
6.1.6 Becton, Dickinson and Company
6.1.7 Siemens Healthineers AG
6.1.8 Tecan Group Ltd
6.1.9 Shimadzu Corporation
7 INVESTMENT ANALYSIS
8 MARKET OPPORTUNITIES AND FUTURE TRENDS